Meridian Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Buy
16,534
+1,981
+14% +$158K 0.04% 353
2025
Q4
$1.39M Buy
14,553
+9,005
+162% +$883K 0.05% 286
2025
Q3
$542K Buy
5,548
+3,392
+157% +$351K 0.02% 455
2025
Q2
$232K Buy
2,156
+40
+2% +$4.05K 0.01% 614
2025
Q1
$213K Buy
+2,116
New +$213K 0.01% 592

Other funds holding BSX

Meridian Wealth Management's BSX Position: Q1 2026 in Review

Meridian Wealth Management increased its Boston Scientific (BSX) stake by 14% in Q1 2026, buying an estimated $158K and bringing the position to 16,534 shares worth $1.04M. The position accounts for 0.04% of the portfolio, ranked #353.

Meridian Wealth Management first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.39M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Meridian Wealth Management held 16,534 shares of Boston Scientific worth $1.04M as of Q1 2026.
  • Meridian Wealth Management bought 1,981 Boston Scientific shares in Q1 2026, an estimated $158K.
  • Boston Scientific made up 0.04% of Meridian Wealth Management's portfolio in Q1 2026, its #353 holding.
  • Meridian Wealth Management first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • Meridian Wealth Management's Boston Scientific position peaked at $1.39M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.